The estimated Net Worth of Pamela G Marrone is at least $2.9 millió dollars as of 6 July 2022. Pamela Marrone owns over 20,000 units of Pro Farm Inc stock worth over $1,759,307 and over the last 11 years he sold MBII stock worth over $248,468. In addition, he makes $894,197 as Director at Pro Farm Inc.
Pamela has made over 28 trades of the Pro Farm Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of MBII stock worth $16,000 on 6 July 2022.
The largest trade he's ever made was exercising 87,954 units of Pro Farm Inc stock on 3 February 2021 worth over $70,363. On average, Pamela trades about 14,445 units every 73 days since 2013. As of 6 July 2022 he still owns at least 2,199,134 units of Pro Farm Inc stock.
You can see the complete history of Pamela Marrone stock trades at the bottom of the page.
Dr. Pamela G. Marrone Ph.D. serves as Director of the Company. Following her retirement, Dr. Marrone continues to serve as a consultant to the Company. Dr. Marrone has also served a member of our board of directors since our inception in 2006. Prior to founding the Company, in 1995 Dr. Marrone founded AgraQuest, Inc. (acquired by Bayer), where she served as chief executive officer until May 2004 and as President or Chairman from such time until March 2006, and where she led teams that discovered and commercialized several bio-based pest management products. She served as founding president and business unit head for Entotech, Inc., a biopesticide subsidiary of Denmark-based Novo Nordisk A/S (acquired by Abbott Laboratories), from 1990 to 1995, and held various positions at the Monsanto Company from 1983 until 1990, where she led the Insect Biology Group, which was involved in pioneering projects in transgenic crops, natural products and microbial pesticides. Dr. Marrone is an author of over a dozen invited publications, an inventor on more than 300 patents and is in demand as a speaker and has served on the boards and advisory councils of numerous professional and academic organizations. In 2016, Dr. Marrone was elected to the Cornell University Board of Trustees and completed her four-year term in July 2020. In February 2019, she was awarded the Lifetime Achievement Award for contributions in biopesticides by BioAg World. In January 2019, she was awarded the “Sustie” award by the Ecological Farming Association for her decades-long leadership in sustainable agriculture. In 2013, Dr. Marrone was named the Sacramento region’s “Executive of the Year” by the Sacramento Business Journal and “Cleantech Innovator of the Year” by the Sacramento Area Regional Technology Alliance and Best Manager with Strategic Vision by Agrow in 2014. Dr. Marrone earned a B.S. in Entomology from Cornell University and a Ph.D. in Entomology from North Carolina State University.
As the Director of Pro Farm Inc, the total compensation of Pamela Marrone at Pro Farm Inc is $894,197. There are no executives at Pro Farm Inc getting paid more.
Pamela Marrone is 63, he's been the Director of Pro Farm Inc since 2020. There are 8 older and 8 younger executives at Pro Farm Inc. The oldest executive at Pro Farm Group Inc is Zachary Wochok, 77, who is the Independent Director.
Pamela's mailing address filed with the SEC is C/O MARRONE BIO INNOVATIONS, INC., 7780-420 BRIER CREEK PARKWAY, RALEIGH, NC, 27617-7882.
Over the last 22 years, insiders at Pro Farm Inc have traded over $9,574,054 worth of Pro Farm Inc stock and bought 9,515,326 units worth $31,165,010 . The most active insiders traders include Ag Science Llc Ospraie Mana..., Advisory Partnersardsley Pa... és Advisory Partners Lp Ardsle.... On average, Pro Farm Inc executives and independent directors trade stock every 49 days with the average trade being worth of $690,868. The most recent stock trade was executed by Pamela G Marrone on 6 July 2022, trading 20,000 units of MBII stock currently worth $16,000.
Marrone Bio Innovations Inc. is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection and plant health that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 500 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®, Zelto® Jet-Oxide® and Jet-Ag® , with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company's product pipeline. MBI's Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Pro Farm Inc executives and other stock owners filed with the SEC include: